Literature DB >> 28002731

Cholesterol Accumulation in CD11c+ Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease.

Ayaka Ito1, Cynthia Hong1, Kazuhiro Oka2, Jon V Salazar1, Cody Diehl3, Joseph L Witztum3, Mercedes Diaz4, Antonio Castrillo4, Steven J Bensinger5, Lawrence Chan2, Peter Tontonoz6.   

Abstract

Liver X receptors (LXRs) are regulators of cholesterol metabolism that also modulate immune responses. Inactivation of LXR α and β in mice leads to autoimmunity; however, how the regulation of cholesterol metabolism contributes to autoimmunity is unclear. Here we found that cholesterol loading of CD11c+ cells triggered the development of autoimmunity, whereas preventing excess lipid accumulation by promoting cholesterol efflux was therapeutic. LXRβ-deficient mice crossed to the hyperlipidemic ApoE-deficient background or challenged with a high-cholesterol diet developed autoantibodies. Cholesterol accumulation in lymphoid organs promoted T cell priming and stimulated the production of the B cell growth factors Baff and April. Conversely, B cell expansion and the development of autoantibodies in ApoE/LXR-β-deficient mice was reversed by ApoA-I expression. These findings implicate cholesterol imbalance as a contributor to immune dysfunction and suggest that stimulating HDL-dependent reverse cholesterol transport could be beneficial in the setting of autoimmune disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  LXR; autoantibodies; autoimmune disease; reverse cholesterol transport

Mesh:

Substances:

Year:  2016        PMID: 28002731      PMCID: PMC5181791          DOI: 10.1016/j.immuni.2016.11.008

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  48 in total

Review 1.  Statin therapy and autoimmune disease: from protein prenylation to immunomodulation.

Authors:  John Greenwood; Lawrence Steinman; Scott S Zamvil
Journal:  Nat Rev Immunol       Date:  2006-05       Impact factor: 53.106

2.  Coordinate regulation of neutrophil homeostasis by liver X receptors in mice.

Authors:  Cynthia Hong; Yoko Kidani; Noelia A-Gonzalez; Tram Phung; Ayaka Ito; Xin Rong; Katrin Ericson; Hanna Mikkola; Simon W Beaven; Lloyd S Miller; Wen-Hai Shao; Philip L Cohen; Antonio Castrillo; Peter Tontonoz; Steven J Bensinger
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

3.  Cholesterol efflux by high density lipoproteins is impaired in patients with active rheumatoid arthritis.

Authors:  Christina Charles-Schoeman; Yuen Yin Lee; Victor Grijalva; Sogol Amjadi; John FitzGerald; Veena K Ranganath; Mihaela Taylor; Maureen McMahon; Harold E Paulus; Srinivasa T Reddy
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

Review 4.  The role of dendritic cells in autoimmunity.

Authors:  Dipyaman Ganguly; Stefan Haak; Vanja Sisirak; Boris Reizis
Journal:  Nat Rev Immunol       Date:  2013-07-05       Impact factor: 53.106

Review 5.  Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR.

Authors:  Anna C Calkin; Peter Tontonoz
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-14       Impact factor: 94.444

6.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

7.  Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism.

Authors:  Antonio Castrillo; Sean B Joseph; Sagar A Vaidya; Margaret Haberland; Alan M Fogelman; Genhong Cheng; Peter Tontonoz
Journal:  Mol Cell       Date:  2003-10       Impact factor: 17.970

8.  Intestinal Phospholipid Remodeling Is Required for Dietary-Lipid Uptake and Survival on a High-Fat Diet.

Authors:  Bo Wang; Xin Rong; Mark A Duerr; Daniel J Hermanson; Per Niklas Hedde; Jinny S Wong; Thomas Q de Aguiar Vallim; Benjamin F Cravatt; Enrico Gratton; David A Ford; Peter Tontonoz
Journal:  Cell Metab       Date:  2016-01-28       Impact factor: 27.287

9.  Ligand activation of LXR beta reverses atherosclerosis and cellular cholesterol overload in mice lacking LXR alpha and apoE.

Authors:  Michelle N Bradley; Cynthia Hong; Mingyi Chen; Sean B Joseph; Damien C Wilpitz; Xuping Wang; Aldons J Lusis; Allan Collins; Willa A Hseuh; Jon L Collins; Rajendra K Tangirala; Peter Tontonoz
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

10.  Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR.

Authors:  Noelia A-Gonzalez; Steven J Bensinger; Cynthia Hong; Susana Beceiro; Michelle N Bradley; Noam Zelcer; Jose Deniz; Cristina Ramirez; Mercedes Díaz; German Gallardo; Carlos Ruiz de Galarreta; Jon Salazar; Felix Lopez; Peter Edwards; John Parks; Miguel Andujar; Peter Tontonoz; Antonio Castrillo
Journal:  Immunity       Date:  2009-07-30       Impact factor: 31.745

View more
  40 in total

1.  Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity.

Authors:  Marit Westerterp; Emmanuel L Gautier; Anjali Ganda; Matthew M Molusky; Wei Wang; Panagiotis Fotakis; Nan Wang; Gwendalyn J Randolph; Vivette D D'Agati; Laurent Yvan-Charvet; Alan R Tall
Journal:  Cell Metab       Date:  2017-05-04       Impact factor: 27.287

Review 2.  The Interconnection Between Immuno-Metabolism, Diabetes, and CKD.

Authors:  Fabrizia Bonacina; Andrea Baragetti; Alberico Luigi Catapano; Giuseppe Danilo Norata
Journal:  Curr Diab Rep       Date:  2019-03-19       Impact factor: 4.810

Review 3.  Metabolic determinants of lupus pathogenesis.

Authors:  Xiangyu Teng; Josephine Brown; Seung-Chul Choi; Wei Li; Laurence Morel
Journal:  Immunol Rev       Date:  2020-03-12       Impact factor: 12.988

Review 4.  Immune cell metabolism in autoimmunity.

Authors:  X Teng; W Li; C Cornaby; L Morel
Journal:  Clin Exp Immunol       Date:  2019-03-11       Impact factor: 4.330

Review 5.  The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.

Authors:  Angela Pirillo; Fabrizia Bonacina; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

6.  FcγRIIb on CD11c+ cells modulates serum cholesterol and triglyceride levels and differentially affects atherosclerosis in male and female Ldlr-/- mice.

Authors:  Jennifer Marvin; Jillian P Rhoads; Amy S Major
Journal:  Atherosclerosis       Date:  2019-04-13       Impact factor: 5.162

Review 7.  Liver X receptors in lipid signalling and membrane homeostasis.

Authors:  Bo Wang; Peter Tontonoz
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

8.  Defective cholesterol metabolism in haematopoietic stem cells promotes monocyte-driven atherosclerosis in rheumatoid arthritis.

Authors:  Dragana Dragoljevic; Michael J Kraakman; Prabhakara R Nagareddy; Devi Ngo; Waled Shihata; Helene L Kammoun; Alexandra Whillas; Man Kit Sam Lee; Annas Al-Sharea; Gerard Pernes; Michelle C Flynn; Graeme I Lancaster; Mark A Febbraio; Jaye Chin-Dusting; Beatriz Y Hanaoka; Ian P Wicks; Andrew J Murphy
Journal:  Eur Heart J       Date:  2018-06-14       Impact factor: 29.983

9.  Acute Loss of Apolipoprotein E Triggers an Autoimmune Response That Accelerates Atherosclerosis.

Authors:  Monica Centa; Kajsa E Prokopec; Manasa G Garimella; Katrin Habir; Lisa Hofste; Julian M Stark; Albert Dahdah; Chris A Tibbitt; Konstantinos A Polyzos; Anton Gisterå; Daniel K Johansson; Nobuyo N Maeda; Göran K Hansson; Daniel F J Ketelhuth; Jonathan M Coquet; Christoph J Binder; Mikael C I Karlsson; Stephen Malin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

10.  Serum lipids are novel predictors for thyroid autoimmunity in the general population with normal TSH levels from a cross-sectional study.

Authors:  Jiarong Li; Zixiao Wang; He Liu; Jinrong Fu; Fengye Qin; Haixia Guan; Wei Wang
Journal:  Endocrine       Date:  2021-05-07       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.